Sec. 562.202. LIMITATIONS ON PRACTICE. A Canadian pharmacy designated by the board under Section 554.016 to dispense prescription drugs to residents in this state may not:
(1) dispense to a resident of this state a prescription drug for which there is not an equivalent drug approved by the United States Food and Drug Administration for sale in the United States;
(2) dispense to a resident of this state a prescription drug that cannot be safely shipped by mail, common carrier, or delivery service;
(3) dispense in one order to a resident of this state a quantity of a prescription drug that exceeds:
(A) a three-month supply; or
(B) the amount ordered by the practitioner;
(4) fill a prescription drug order for a consumer who is a resident of this state that the consumer indicates is the consumer's first prescription for that drug; or
(5) dispense to a resident of this state any of the following:
(A) a substance designated as a controlled substance under Chapter 481, Health and Safety Code (Texas Controlled Substances Act);
(B) a biological product, as described by Section 351, Public Health Service Act (42 U.S.C. Section 262);
(C) an infused drug, including a peritoneal dialysis solution;
(D) an intravenously injected drug; or
(E) a drug that is inhaled during surgery.
Added by Acts 2005, 79th Leg., Ch. 1345 (S.B. 410), Sec. 43, eff. September 1, 2005.
Section: Previous 562.1085 562.1086 562.109 562.110 562.111 562.112 562.151 562.152 562.153 562.154 562.155 562.156 562.201 562.202 562.203 NextLast modified: September 28, 2016